InVivo Therapeutics Corporation Announces New Clinical Trial Site For Neuro-Spinal Scaffold
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that UC Davis Medical Center in Sacramento, CA has been added as a clinical site in the company’s ongoing IDE pilot study of its Neuro-Spinal Scaffold in patients with acute spinal cord injury (SCI). The medical center serves a 65,000 square-mile territory that includes 33 counties and 6 million residents across northern and central California.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.